| Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 | 312 | 2018 |
| A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ... Cancer 125 (18), 3184-3197, 2019 | 103 | 2019 |
| Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group … V Patil, V Noronha, SB Dhumal, A Joshi, N Menon, A Bhattacharjee, ... The Lancet Global Health 8 (9), e1213-e1222, 2020 | 74 | 2020 |
| Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma VM Patil, V Noronha, A Joshi, AB Choughule, A Bhattacharjee, R Kumar, ... ESMO open 2 (1), e000168, 2017 | 65 | 2017 |
| Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer VM Patil, V Noronha, A Joshi, S Dhumal, M Mahimkar, A Bhattacharjee, ... Journal of clinical oncology 37 (32), 3032-3041, 2019 | 60 | 2019 |
| Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen … J Bajpai, A Chandrasekharan, V Talreja, V Simha, MV Chandrakanth, ... European Journal of Cancer 85, 49-58, 2017 | 47 | 2017 |
| Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia J Bajpai, S Kagwade, A Chandrasekharan, S Dandekar, S Kanan, ... The Breast 49, 187-193, 2020 | 43 | 2020 |
| Salvage surgery in head and neck cancer: Does it improve outcomes? VM Patil, V Noronha, S Thiagarajan, A Joshi, A Chandrasekharan, ... European Journal of Surgical Oncology 46 (6), 1052-1058, 2020 | 35 | 2020 |
| Outcomes in treatment-naïve patients with metastatic extremity osteosarcoma treated with OGS-12, a novel non–high-dose methotrexate–based, dose-dense combination chemotherapy … J Bajpai, A Chandrasekharan, V Simha, V Talreja, A Karpe, N Pandey, ... Journal of global oncology 4, 1-10, 2018 | 23 | 2018 |
| Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer. V Noronha, A Joshi, VM Patil, J Agarwal, SG Laskar, AN Budrukkar, ... Journal of Clinical Oncology 35 (15_suppl), 6007-6007, 2017 | 19 | 2017 |
| Expectations and preferences for palliative chemotherapy in head and neck cancers patients V Patil, A Joshi, V Noronha, J Deodhar, A Bhattacharjee, S Dhumal, ... Oral oncology 63, 10-15, 2016 | 18 | 2016 |
| Distress management in patients with head and neck cancer before start of palliative chemotherapy: a practical approach V Patil, V Noronha, A Joshi, J Deodhar, S Goswami, S Chakraborty, ... Journal of Global Oncology 4 (1), 1-10, 2018 | 17 | 2018 |
| Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer V Noronha, VM Patil, A Joshi, M Mahimkar, U Patel, MK Pandey, ... Oncotarget 11 (4), 399, 2020 | 15 | 2020 |
| Osteosarcoma journey over two decades in India: Small steps, big changes J Bajpai, A Chandrasekharan, V Simha, T Mandal, K Shah, S Hingmare, ... Pediatric blood & cancer 66 (9), e27877, 2019 | 15 | 2019 |
| Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer A Joshi, V Patil, V Noronha, S Dhumal, N Pande, A Chandrasekharan, ... Oral Oncology 75, 54-60, 2017 | 15 | 2017 |
| A tale of two patients A Chandrasekharan Cancer Research, Statistics, and Treatment 3 (1), 1-2, 2020 | 13 | 2020 |
| Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients V Patil, A Joshi, V Noronha, A Bhattacharjee, S Dhumal, ... South Asian Journal of Cancer 7 (04), 249-252, 2018 | 12 | 2018 |
| Shadow study: Randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy VM Patil, N Pande, A Chandrasekharan, R Tonse, R Krishnatry, JS Goda, ... CNS oncology 7 (02), CNS14, 2018 | 12 | 2018 |
| Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial VM Patil, N Menon, A Chatterjee, R Tonse, A Choudhari, A Mahajan, ... EClinicalMedicine 49, 2022 | 10 | 2022 |
| Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers VM Patil, V Noronha, A Joshi, V Agarwala, V Muddu, A Ramaswamy, ... Indian journal of cancer 54 (1), 20-24, 2017 | 9 | 2017 |
